Kinetics and performance of the Abbott architect SARS-CoV-2 IgG antibody assayAbbott 건축가 SARS-CoV-2 IgG 항체 분석의 역학 및 성능Comment Published on 2020-12-012022-09-12 Journal: The Journal of Infection [Category] MERS, SARS, 진단, [키워드] Abbott Kinetics SARS-CoV-2 IgG antibody [DOI] 10.1016/j.jinf.2020.07.031 PMC 바로가기 [Article Type] Comment
Longitudinal characterization of the IgM and IgG humoral response in symptomatic COVID-19 patients using the Abbott ArchitectArticle Published on 2020-12-012023-06-19 Journal: Journal of Clinical Virology [Category] MERS, [키워드] Abbott coronavirus SARS-CoV-2 IgG SARS-CoV-2 IgM. [DOI] 10.1016/j.jcv.2020.104663 PMC 바로가기
Cardiac troponin I in SARS-CoV-2-patients: The additional prognostic value of serial monitoringSARS-CoV-2-환자의 심장 트로포닌 I: 연속 모니터링의 추가적인 예후 가치Article Published on 2020-12-012022-09-11 Journal: Clinica chimica acta; international journal of cli [Category] MERS, SARS, 바이오마커, [키워드] 113 patient 113 patients Abbott Abbott Diagnostics Admission approach Architect Biomarkers cardiac cardiac complication Cardiac complications cardiac troponin carried Clinical management clinically consecutive patient described died disease Diseases epidemiological female FIVE five groups group heparin High-sensitivity Troponin I Hospital stay hypoxia ICU information Injury kinetic Kinetic release lithium Major male median Microbiology pandemic disease Patient plasma sample plasma samples Prognosis Prognostic value risk SARS-CoV-2 SARS-CoV-2 patient SARS-CoV-2 patients sensitive sensitivity Serial monitoring. severe hypoxia STAT troponin troponin I Variation [DOI] 10.1016/j.cca.2020.09.036 PMC 바로가기 [Article Type] Article
Detection of SARS-CoV-2 antibodies is insufficient for the diagnosis of active or cured COVID-19SARS-CoV-2 항체의 검출은 활성 또는 완치된 COVID-19의 진단에 충분하지 않습니다.Article Published on 2020-11-162022-09-01 Journal: Scientific Reports [Category] 진단, 치료기술, [키워드] Abbott antibody Asymptomatic clinical suspicion Cohort cohorts cohorts of patient COVID-19 COVID-19 pandemic cured detection diagnosed Diagnosis diagnostic Diagnostic markers diagnostic value emergency department hospital Hospitalized IgG IgGs IgM Infectious-disease diagnostics PanBio Patient Rapid test sampling SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 IgG sensitivity serum antibodies serum antibody specificity subjects was done [DOI] 10.1038/s41598-020-76914-5 PMC 바로가기 [Article Type] Article
Evaluation of SARS-CoV-2 IgG antibody response in PCR positive patients: Comparison of nine tests in relation to clinical dataPCR 양성 환자에서 SARS-CoV-2 IgG 항체 반응 평가: 임상 데이터에 대한 9가지 검사 비교Research Article Published on 2020-10-272022-08-13 Journal: PLoS ONE [Category] Biochemistry, COVID-19, MERS, SARS, [키워드] Abbott addressed antibody Antibody test Antibody testing antibody tests asymptomatic patients biosensor Clinical data Clinical practice clinical symptom Clinical symptoms controls correlated correlation COVID-19 patient DiaSorin different time points early stage epidemiological studies epitope Euroimmun explain group highlight house LIPS nine patient groups PCR positive Previous studies previous study ranged Roche S-RBD SARS-CoV-2 antibody test SARS-CoV-2 antibody testing SARS-CoV-2 antibody tests SARS-CoV-2 IgG antibody sensitivity Sensitivity and specificity serum sample serum samples Seven SNIBE specificity symptom onset target protein Variation Viral Viral antigen was performed [DOI] 10.1371/journal.pone.0237548 PMC 바로가기 [Article Type] Research Article
Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders경증 및 중증 COVID-19 감염 후 SARS-CoV-2에 대한 혈청-IgG 반응 및 IgG 무반응자 분석Research Article Published on 2020-10-212022-08-13 Journal: PLoS ONE [Category] COVID-19, Medicine and Health Sciences, MERS, SARS, [키워드] Abbott Abbott Laboratories Abbott Laboratory age Analysis antibody Antibody titers Architect clinically Cohort cohort of patient Concentration COVID-19 COVID-19 patient detectable develop female Follow-up house iFlash IgG IgG antibodies IgG antibody IgG level IgG responses Immunity imperative Interpretation knowledge median Mild Mild symptom mild symptoms Neutralizing antibodies non-responder Nucleocapsid proteins Patient preserved quantified Receptor binding remained response Result SARS-CoV-2 SARS-CoV-2-specific IgG Seroconversion seroconvert seroconverted Serological assay seronegative serum severe COVID-19 Severe COVID-19 Infection severe symptom severe symptoms severity of symptoms significantly shorter specific IgG antibodies spike and nucleocapsid proteins spike-protein symptom onset time virus-neutralizing antibodies virus-neutralizing antibody [DOI] 10.1371/journal.pone.0241104 PMC 바로가기 [Article Type] Research Article
Correlation of ELISA method with three other automated serological tests for the detection of anti-SARS-CoV-2 antibodiesResearch Article Published on 2020-10-062022-10-28 Journal: PLoS ONE [Category] COVID-19, MERS, SARS, [키워드] Abbott anti-SARS-CoV-2 antibody approved automated Centaur characteristic COVID-19 outbreak diagnostic DiaSorin early diagnosis ELISA Emergency use Emergency use authorization estimate EUA facilitated health emergency highlight immunoassay Numerous performed positive Public random Roche SARS-CoV-2 serologic antibody serological test Siemen tested Total [DOI] 10.1371/journal.pone.0240076 PMC 바로가기 [Article Type] Research Article
Postinfectious Onset of Myasthenia Gravis in a COVID-19 PatientNeurology Published on 2020-10-062022-11-01 Journal: Frontiers in Neurology [Category] COVID-19, [키워드] Abbott accompanied Admission Anosmia/ageusia antibody chloride clinical assessment coronavirus COVID-19 COVID-19 patient DiaSorin Diplopia double vision female Fever Germany Hannover Intravenous immunoglobulin limb medical record mild respiratory symptom mild respiratory symptoms Myasthenia neurological neurological manifestation ocular oculomotor paresis Onset Patient persistence Positive test Postinfectious postinfectious myasthenia gravis receptor SARS-CoV-2 School serological test serum suffered Symptom syndrome the patient treated was obtained written Informed Consent [DOI] 10.3389/fneur.2020.576153 PMC 바로가기 [Article Type] Neurology
Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in TaiwanResearch Article Published on 2020-10-012022-10-31 Journal: Emerging Microbes & Infections [Category] COVID-19, MERS, SARS, [키워드] 2019-nCoV 95% CI 95% confidence interval Abbott Abbott SARS-CoV-2 IgG acute respiratory syndrome antibody Antibody Response antibody tests autoantibodies Characteristics chemiluminescence chemiluminescence immunoassay chemiluminescence immunoassays CMV coronavirus coronavirus disease COVID-19 COVID-19 infection cross-reactivity demonstrated Diagnosis diagnosis of COVID-19 diagnostic evaluate FIVE IgG/IgM antibody Infection Interpretation lateral flow immunoassay Lateral flow immunoassays LFIAs multicenter non-COVID-19 patient Patient patient with COVID-19 patients with COVID-19 Pneumonia Rapid response Retrospective study risk Roche SARS-CoV-2 sensitivity sera Seroconversion seroconversion time serological serological test serum sample specificity suggested symptom onset Taiwan Test [DOI] 10.1080/22221751.2020.1825016 PMC 바로가기 [Article Type] Research Article
SARS-CoV-2 Seroprevalence among a Southern U.S. Population Indicates Limited Asymptomatic Spread under Physical Distancing MeasuresResearch Article Published on 2020-09-292022-10-29 Journal: mBio [Category] COVID-19, SARS, [키워드] Abbott affected African American antibody Antibody test Asymptomatic asymptomatic individual authorization Care CLIA Clinical symptoms clinics Cluster Cohort cohort study Community coronavirus COVID-19 COVID-19 pandemic effective Emergency examined General population Health index case Infection infections Inpatient Limited low-density measure multicenter North outbreak participant Participants performed physical distancing Population populations positive positive individual Prevalence primary care public health measure reported respiratory pathogen SARS-CoV-2 SARS-CoV-2 IgG Seroprevalence Spread symptomatic infections the SARS-CoV-2 was performed white [DOI] 10.1128/mBio.02426-20 PMC 바로가기 [Article Type] Research Article